Skip to content

Mark Malyak, MD

NPI 1659365211ActiveIndividual· Internal Medicine, Rheumatology· Denver, CO

Internal Medicine, Rheumatology (MD) in Denver, Colorado, licensed in CO, with an NPI issued in September 2005. Part D covered 172 prescriptions written in 2024, 68% of them generic. Abbvie Inc. reported $17.01 in payments in 2024, mostly food and beverage.

Overview

NPI1659365211
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedSep 9, 2005
Last updated in NPPESJan 22, 2024
Certified by providerJan 22, 2024

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Rheumatology Primary207RR0500X31151CO

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)172 · 335 30-day fills
Patients105
Total drug cost$220,664
Generic share68% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$17.01 · 1 payment from 1 company

Top paying companies in 2024

CompanyAmountPayments
Abbvie Inc.$17.011

What the 2024 payments were for

  • Food and Beverage$17.01 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other rheumatologists in Denver

All 61 rheumatologists in Denver · All rheumatologists in Colorado